Dr. Scott M. Rocklage is acting Managing Partner at 5AM Ventures, and is still reaching new heights daily. You can take a great look at Dr. Scott Rocklage’s journey, and see the level of diligence and determination it took to reach this height. Scott Rocklage first obtained his Bachelor of Science Degree in Chemistry from the University of California, Berkley. He then decided to continue his education at the Massachusetts Institute of Technology where he earned his PhD in Chemistry. While attending MIT, Rocklage had the opportunity to study under Richard R. Schrock, a receiver of the 2005 Nobel Prize in Chemistry. While working with Dr Schrock he co-invented over 30 U.S. patents. With all of his newfound knowledge, Dr. Rocklage obtained over thirty years of healthcare managing experience, holding very powerful positions in the nation’s top pharmaceutical companies.
These titles include: CEO and Chairman of Cubist Pharmaceuticals, Board Chairman of Relypsa, CEO and President of Nycomed Salutar, and many more. He currently serves as Board Chairman at Rennovia, INC., Board Member at Kinestral, as well as Cidara. Dr. Scott Rocklage has made sure to waste no time in furthering his career. The doctor has made a name for himself in every area of healthcare, putting his best foot forward to deliver amazing results for not only his community, but also to the country (maybe even the world!). Dr. Rocklage managed to lead the U.S Food and Drug Administration to approve three U.S. New Drug Applications, and has peer-reviewed over one hundred publications. Dr. Scott M. Rocklage has been dedicating his entire life for the greater good of the people, which is not only commendable but inspiring. One can only hope to achieve the goals he has set in his lifetime and resume him.